Studies have confirmed that patients infected with COVID-19 can produce inflammation-induced degradation of the GAC layer of endothelial cells, and SDC1 can be used as an important parameter to assess GAC damage (Vollenberg et al., 2021). Here, SDC1 is linked to COVID-19.